Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Immuneering Corporation, 3 years.
Immuneering Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immuneering Corporation June 11, 202692.9%
-
Immuneering Corporation June 14, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2026 | Immuneering Corporation | Open-market purchase | +20,000 | $4.35 | $87,000 |
| Oct 3, 2025 | Immuneering Corporation | Open-market purchase | +7,500 | $6.67 | $50,025 |
| Sep 30, 2025 | Immuneering Corporation | Open-market purchase | +7,500 | $7.03 | $52,725 |
| Sep 29, 2025 | Immuneering Corporation | Open-market purchase | +5,000 | $7.18 | $35,900 |
| Jun 18, 2025 | Immuneering Corporation | Open-market purchase | +25,000 | $2.53 | $63,250 |
| Mar 22, 2024 | Immuneering Corporation | Open-market purchase | +25,000 | $2.55 | $63,750 |
| Mar 19, 2024 | Immuneering Corporation | Open-market purchase | +25,000 | $2.56 | $64,000 |
| Mar 18, 2024 | Immuneering Corporation | Open-market purchase | +45,024 | $2.31 | $104,005 |
| Mar 18, 2024 | Immuneering Corporation | Open-market purchase | +4,976 | $3.05 | $15,177 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.